Jully Oyama
Research Subjects
Jully Oyama has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Maria Valdrinez Campana Lonardoni
State University of Maringá (UEM) Maringá Paraná Brazil
4 shared publications Daniele Stéfanie Sara Lopes Lera-Nonose
Graduate Program in Health Sciences, State University of Maringá, Colombo Avenue, 5790, Postal Code 87020-900, Maringá, Paraná, Brazil
3 shared publications- Jorge Juarez Vieira Teixeira
State University of Maringá (UEM) Maringá Paraná Brazil
3 shared publications Thaís Gomes Verzignassi Silveira
Department of Clinical Analysis and Biomedicine, State University of Maringá, Colombo Avenue, 5790, Postal Code 87020-900, Maringá, Paraná, Brazil
3 shared publications- Thaís Gomes Verzignassi Silveira
Departamento de Análises Clínicas e Biomedicina, Universidade Estadual de Maringá, Maringá, Paraná, Brazil
3 shared publications - Áquila Carolina Fernandes Herculano Ramos-Milaré
State University of Maringá (UEM) Maringá Paraná Brazil
3 shared publications
Latest Publications
- 14 November 2025
- Published by Taylor & Francis in Natural Product Research
- p. 1-20
Therapeutic potential of medicinal plants and compounds in mitigating 5-fluorouracil-induced intestinal mucositis: a systematic review
The chemotherapy drug 5-fluorouracil (5-FU) is extensively utilised, however its its administration is extremely restricted due to its serious adverse effects, including intestinal mucositis, which can lead to the patient's death. Our objective was to identify plant options or derived utilised in the treatment of 5-FU-induced intestinal mucositis and their efficacy.The study used the Preferred Report Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 25 articles were selected from the databases and subjected to descriptive and bias analysis. A variety of medicinal plants or compounds were evaluated for their effects on intestinal mucositis triggered by 5-FU, but some stood out for more efficiently attenuating changes related to IM, including oxidative stress, inflammation, histology and clinical status of the animals. The data obtained could clarify and advance clinical trials. Treatment with medicinal plants can improve the quality of life of cancer patients undergoing chemotherapy with 5-FU.
- 14 November 2025
- Published by Taylor & Francis in Natural Product Research
- p. 1-20
Therapeutic potential of medicinal plants and compounds in mitigating 5-fluorouracil-induced intestinal mucositis: a systematic review
The chemotherapy drug 5-fluorouracil (5-FU) is extensively utilised, however its its administration is extremely restricted due to its serious adverse effects, including intestinal mucositis, which can lead to the patient's death. Our objective was to identify plant options or derived utilised in the treatment of 5-FU-induced intestinal mucositis and their efficacy.The study used the Preferred Report Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 25 articles were selected from the databases and subjected to descriptive and bias analysis. A variety of medicinal plants or compounds were evaluated for their effects on intestinal mucositis triggered by 5-FU, but some stood out for more efficiently attenuating changes related to IM, including oxidative stress, inflammation, histology and clinical status of the animals. The data obtained could clarify and advance clinical trials. Treatment with medicinal plants can improve the quality of life of cancer patients undergoing chemotherapy with 5-FU.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 56, e12693
In vitro effects of lapachol and β-lapachone against Leishmania amazonensis
Leishmaniasis is a neglected disease that affects millions of people worldwide, and special attention should be given to treatment because the available drugs have limitations, which can lead to low therapeutic adherence and parasitic resistance. This study evaluated the activity of the bioactive naphthoquinones, lapachol and β-lapachone, against Leishmania amazonensis. The cell alterations were evaluated in vitro on promastigote and amastigote forms. The lethal dose (LD50) at 24, 48, and 72 h on the promastigote's forms using lapachol was 75.60, 72.82, and 58.85 μg/mL and for β-lapachone was 0.65, 1.24, and 0.71 μg/mL, respectively. The naphthoquinones significantly inhibited the survival rate of L. amazonensis amastigotes at 83.11, 57.59, and 34.95% for lapachol (82.28, 41.14, and 20.57 µg/mL), and 78.49, 83.25, and 80.22% for β-lapachone (3.26, 1.63, and 0.815 µg/mL). The compounds on the promastigote's forms led to the loss of mitochondrial membrane potential, induced changes in the integrity of the membrane, caused damage to cells suggestive of the apoptotic process, and showed inhibition of tumor necrosis factor (TNF)-α and interleukin (IL)-6 production. The results showed that these naphthoquinones are promising candidates for research on new drugs with anti-Leishmania activity derived from natural products.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 56, e12693
Open AccessIn vitro effects of lapachol and β-lapachone against Leishmania amazonensis
Leishmaniasis is a neglected disease that affects millions of people worldwide, and special attention should be given to treatment because the available drugs have limitations, which can lead to low therapeutic adherence and parasitic resistance. This study evaluated the activity of the bioactive naphthoquinones, lapachol and β-lapachone, against Leishmania amazonensis. The cell alterations were evaluated in vitro on promastigote and amastigote forms. The lethal dose (LD50) at 24, 48, and 72 h on the promastigote's forms using lapachol was 75.60, 72.82, and 58.85 μg/mL and for β-lapachone was 0.65, 1.24, and 0.71 μg/mL, respectively. The naphthoquinones significantly inhibited the survival rate of L. amazonensis amastigotes at 83.11, 57.59, and 34.95% for lapachol (82.28, 41.14, and 20.57 µg/mL), and 78.49, 83.25, and 80.22% for β-lapachone (3.26, 1.63, and 0.815 µg/mL). The compounds on the promastigote's forms led to the loss of mitochondrial membrane potential, induced changes in the integrity of the membrane, caused damage to cells suggestive of the apoptotic process, and showed inhibition of tumor necrosis factor (TNF)-α and interleukin (IL)-6 production. The results showed that these naphthoquinones are promising candidates for research on new drugs with anti-Leishmania activity derived from natural products.
- 15 April 2021
- Published by Taylor & Francis in Immunotherapy
- Vol. 13 (8) , 693-721
Three Decades of Clinical Trials on Immunotherapy for Human Leishmaniases: a Systematic Review and Meta-Analysis
Aim: Current treatments for leishmaniases are not satisfactory, thus alternatives are needed. We searched for clinical trials with immunotherapeutic approaches for patients with leishmaniasis. Mate...
- 15 April 2021
- Published by Taylor & Francis in Immunotherapy
- Vol. 13 (8) , 693-721
Three Decades of Clinical Trials on Immunotherapy for Human Leishmaniases: a Systematic Review and Meta-Analysis
Aim: Current treatments for leishmaniases are not satisfactory, thus alternatives are needed. We searched for clinical trials with immunotherapeutic approaches for patients with leishmaniasis. Mate...
- 3 August 2020
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 147 (13) , 1392-1407
Effect of essential oils on Leishmania amazonensis: a systematic review
This systematic review investigated the evidence for the therapeutic potential of essential oils (EOs) against Leishmania amazonensis. We searched available scientific publications from 2005 to 2019 in the PubMed and Web of Science electronic databases, according to PRISMA statement. The search strategy utilized descriptors and free terms. The EOs effect of 35 species of plants identified in this systematic review study, 45.7% had half of the maximal inhibitory concentration (IC50) 10 < IC50 ⩽ 50 μg mL−1 and 14.3% had a 10 < IC50μg mL−1 for promastigote forms of L. amazonensis. EOs from Cymbopogon citratus species had the lowest IC50 (1.7 μg mL−1). Among the plant species analyzed for activity against intracellular amastigote forms of L. amazonensis, 39.4% had an IC50 10 < IC50 ⩽ 50 μg mL−1, and 33.3% had an IC50 10 < IC50μg mL−1. Aloysia gratissima EO showed the lowest IC50 (0.16 μg mL−1) for intracellular amastigotes. EOs of Chenopodium ambrosioides, Copaifera martii and Carapa guianensis, administered by the oral route, were effective in reducing parasitic load and lesion volume in L. amazonensis-infected BALB/c mice. EOs of Bixa orellana and C. ambrosioides were effective when administered intraperitoneally. Most of the studies analyzed in vitro and in vivo for the risk of bias showed moderate methodological quality. These results indicate a stimulus for the development of new phytotherapy drugs for leishmaniasis treatment.
- 3 August 2020
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 147 (13) , 1392-1407
Effect of essential oils on Leishmania amazonensis: a systematic review
This systematic review investigated the evidence for the therapeutic potential of essential oils (EOs) against Leishmania amazonensis. We searched available scientific publications from 2005 to 2019 in the PubMed and Web of Science electronic databases, according to PRISMA statement. The search strategy utilized descriptors and free terms. The EOs effect of 35 species of plants identified in this systematic review study, 45.7% had half of the maximal inhibitory concentration (IC50) 10 < IC50 ⩽ 50 μg mL−1 and 14.3% had a 10 < IC50μg mL−1 for promastigote forms of L. amazonensis. EOs from Cymbopogon citratus species had the lowest IC50 (1.7 μg mL−1). Among the plant species analyzed for activity against intracellular amastigote forms of L. amazonensis, 39.4% had an IC50 10 < IC50 ⩽ 50 μg mL−1, and 33.3% had an IC50 10 < IC50μg mL−1. Aloysia gratissima EO showed the lowest IC50 (0.16 μg mL−1) for intracellular amastigotes. EOs of Chenopodium ambrosioides, Copaifera martii and Carapa guianensis, administered by the oral route, were effective in reducing parasitic load and lesion volume in L. amazonensis-infected BALB/c mice. EOs of Bixa orellana and C. ambrosioides were effective when administered intraperitoneally. Most of the studies analyzed in vitro and in vivo for the risk of bias showed moderate methodological quality. These results indicate a stimulus for the development of new phytotherapy drugs for leishmaniasis treatment.
- 1 June 2020
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 30, 101682
Photodynamic therapy in wound healing in vivo: a systematic review
- 1 June 2020
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 30, 101682
Photodynamic therapy in wound healing in vivo: a systematic review
- 1 April 2019
- Published by Elsevier in Acta Tropica
- Vol. 192, 11-21
Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy
- 1 April 2019
- Published by Elsevier in Acta Tropica
- Vol. 192, 11-21
Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy
- Top Cited Papers
- 1 March 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 21, 294-305
Contribution of photodynamic therapy in wound healing: A systematic review
- 1 March 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 21, 294-305
Top Cited PapersContribution of photodynamic therapy in wound healing: A systematic review
- Open Access
- 15 February 2018
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 60, e3
American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case
This clinical case presents a patient with a raised and ulcerative lesion with erythematous edges in the mouth, on the lower lip that was unsuccessfully treated as herpes labialis. Clinical data and laboratory tests (Montenegro skin test, indirect immunofluorescence, direct parasite search and polymerase chain reaction) led to the diagnosis of American tegumentary leishmaniasis caused by Leishmania (Viannia) sp. Treatment with pentavalent antimonial (Glucantime®) for 120 days was not effective and administration of amphotericin B for 30 days resulted in wound healing. Glucantime® treatment protocol was longer than the recommended by the Brazilian Ministry of Health in the handbook of mucosal leishmaniasis. This suggests that amphotericin B should have been administered earlier, preventing the psychological and social problems faced by the patient. This study reports a rare clinical case of primary mucosal leishmaniasis on the lip that had a delayed diagnosis, highlighting the precariousness in the management of disease and showing that, despite the importance of leishmaniasis in Brazil, it is still neglected by health professionals.
- 15 February 2018
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 60, e3
Open AccessAmerican tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case
This clinical case presents a patient with a raised and ulcerative lesion with erythematous edges in the mouth, on the lower lip that was unsuccessfully treated as herpes labialis. Clinical data and laboratory tests (Montenegro skin test, indirect immunofluorescence, direct parasite search and polymerase chain reaction) led to the diagnosis of American tegumentary leishmaniasis caused by Leishmania (Viannia) sp. Treatment with pentavalent antimonial (Glucantime®) for 120 days was not effective and administration of amphotericin B for 30 days resulted in wound healing. Glucantime® treatment protocol was longer than the recommended by the Brazilian Ministry of Health in the handbook of mucosal leishmaniasis. This suggests that amphotericin B should have been administered earlier, preventing the psychological and social problems faced by the patient. This study reports a rare clinical case of primary mucosal leishmaniasis on the lip that had a delayed diagnosis, highlighting the precariousness in the management of disease and showing that, despite the importance of leishmaniasis in Brazil, it is still neglected by health professionals.
- 30 September 2013
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 37 (3) , 312-320
Qualidade microbiológica da água para consumo humano em instituição de ensino de Maringá-PR
- 30 September 2013
- Published by Centro Universitario Sao Camilo - Sao Paulo in O Mundo da Saúde
- Vol. 37 (3) , 312-320
Qualidade microbiológica da água para consumo humano em instituição de ensino de Maringá-PR